post-add

Articles for Healthcare

India Joins International Medical Device Regulators Forum as Affiliate Member

In a significant move, India has become an affiliate member of the International Medical Device Regulators Forum (IMDRF), a global group focused on harmonising medical device regulations, the Union Health Ministry announced on Thursday.

Read More
CK Birla Hospital Performs Bilateral Hip Replacement On 65-Year-Old Woman Weighing 23kg

In a medical achievement, CK Birla Hospital, Delhi successfully performed India’s low-weight bilateral hip replacement surgery on a 65-year-old woman weighing just 23 kg.

Read More
North-Eastern States Of India Faces Escalating Cancer Crisis, Experts Call For Unified Action

Regional cancer rates in the North-East have surged, with states like Manipur, Sikkim, and Tripura reporting alarming increases. In 2022, Manipur recorded a 6.48 per cent rise in cancer cases, significantly above the national average of 2.45 per cent

Read More
RGCIRC Marks 28 Years Of Cancer Care Excellence, Announces Expansion Plans

The Rajiv Gandhi Cancer Institute and Research Centre (RGCIRC) has announced plans to expand its operations across the National Capital Region (NCR) to provide quality cancer treatment to more people.

Read More
In Memoriam: Dr Sandip Chatterjee, Renowned Neurosurgeon and Advocate, Passes Away

It is with deep sadness that we announce the passing of Dr Sandip Chatterjee, one of India’s most esteemed neurosurgeons, and a remarkable human being

Read More
Chennai Hosts Heartwarming Meeting Between Blood Stem Cell Donor & 11-Year-Old Survivor

Fanconi Anemia is a rare genetic disorder that affects the bone marrow’s ability to produce blood cells

Read More
ENTOD Pharmaceuticals Seeks Reinstatement of Approval for Its Eye Drops Following Suspension by DCGI

Mumbai-based ENTOD Pharmaceuticals is working with the Drug Controller General of India (DCGI) to address concerns over its recently approved Pilocarpine Hydrochloride Ophthalmic Solution USP 1.25per cent w/v, branded as PresVu eye drops. Approved on August 6 for the treatment of presbyopia in adults, the drug's approval was suspended by DCGI on September 10 after healthcare professionals raised concerns.

Read More
Growing Threat Of Retinal Disorders: India Faces Alarming Rise In Vision Loss

Globally, 90per cent of blindness is preventable or treatable, yet over 1 billion people are living with some form of vision loss. The global economic burden of vision impairment was estimated at $410.9 billion (about $1,300 per person in the US) in 2020 alone.

Read More
ICMR Report Warns of Rising Antibiotic Resistance In UTIs, Typhoid, And Pneumonia

The report examined 99,492 samples from public and private healthcare facilities across the country. These samples, collected from areas such as the blood, urine, and respiratory tract, were tested against bacteria like E. coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Staphylococcus aureus.

Read More
AstraZeneca India Receives CDSCO Nod For Additional Indication Of Durvalumab In Lung Cancer Treatment

According to the GLOBOCAN 2022 data, lung cancer is the fourth leading cause of cancer-related mortality in India. NSCLC accounts for a significant proportion of these cases, with about 15 per cent of patients having resectable disease, this data underscores the importance of targeted treatment options.

Read More

Subscribe to our newsletter to get updates on our latest news